Gut Microbiome as a Potential Marker of Hematologic Recovery Following Induction Therapy in Acute Myeloid Leukemia Patients

ABSTRACT Background The management of acute myeloid leukemia (AML) is hindered by treatment‐related toxicities and complications, particularly cytopenia, which remains a leading cause of mortality. Given the pivotal role of the gut microbiota (GM) in hemopoiesis and immune regulation, we investigate...

Descripció completa

Dades bibliogràfiques

Autors principals:	Valentina Salvestrini, Gabriele Conti, Federica D'Amico, Gianluca Cristiano, Marco Candela, Michele Cavo, Silvia Turroni, Antonio Curti
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2025-02-01
Col·lecció:	Cancer Medicine
Matèries:	acute myeloid leukemia gut microbiome hematological recovery induction therapy
Accés en línia:	https://doi.org/10.1002/cam4.70501
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!